Morgan Stanley »

Avalo Therapeutics Ord shares owned by Morgan Stanley

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $124 10 12.43
2024-03-31 $848 39 21.75
2023-12-31 $400 44 9.10